Heramed Ltd risk profile
57 Elevated one input has moved against it
Measured 1 September 2026 from HMD's filed statements. Recomputed nightly.
57 (Elevated), driven by Competitive position at 91, over 4 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 72 | Stretched | Volatile | One-year price volatility — 74.1% |
| Operating pressure | 1 | Contained | Easing | Input-cost exposure — 0.03 |
| Cash conversion | Reads operating_cashflow, capital_expenditure, free_cashflow, net_income and revenue. No reading is stored for this company. | |||
| Leverage and coverage | 36 | Normal | Stable | Interest cover — -946.44x |
| Competitive position | 91 | Acute | Stable | Operating-margin gap against peers — -1,132.9 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.